Statement Of Changes In Equity [Abstract]

Sopharma Trading AD - Filing #6022496

Concept	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	25 436 BGN	94 545 BGN	—	—	—	—	225,000 BGN	—	—	55 181 BGN	21 441 BGN	34 276 BGN	868,000 BGN	—	24 912 BGN	225,000 BGN	25 773 BGN	—	50 463 BGN	—	—	84 900 BGN	—	—	797,000 BGN	34 276 BGN	—	—	10 723 BGN	22 595 BGN	392,000 BGN	34 276 BGN	789,000 BGN	29 609 BGN	76 938 BGN
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	- BGN	- BGN	9 080 BGN	9 080 BGN	—	- BGN	- BGN	—	—	—	—	- BGN	—	—	—	- BGN	—	- BGN	- BGN	—	- BGN	- BGN	—	—	8 050 BGN	8 050 BGN	—	—	—	—	—	—	—
Other comprehensive income	—	—	- BGN	- BGN	565,000 BGN	494,000 BGN	—	- BGN	- BGN	—	—	—	—	71,000 BGN	—	—	—	- BGN	—	- BGN	87,000 BGN	—	8,000 BGN	- BGN	—	—	88,000 BGN	9,000 BGN	—	—	—	—	—	—	—
Comprehensive income	—	—	- BGN	- BGN	9 645 BGN	9 574 BGN	—	- BGN	- BGN	—	—	—	—	71,000 BGN	—	—	—	- BGN	—	- BGN	87,000 BGN	—	8,000 BGN	- BGN	—	—	7 962 BGN	8 041 BGN	—	—	—	—	—	—	—